The androgen receptor (AR) is a member of the steroid receptor superfamily that plays an important role in male sexual differentiation and prostate cell proliferation. Mutations or abnormal expression of AR in prostate cancer can play a key role in the process that changes prostate cancer from androgen-dependent to an androgen-independent stage. Using a yeast two-hybrid system, we were able to isolate a ligand-dependent AR-associated protein (ARA 70 ), which functions as an activator to enhance AR transcriptional activity 10-fold in the presence of 10 ؊10 M dihydrotestosterone or 10 ؊9 M testosterone, but not 10 ؊6 M hydroxyf lutamide in human prostate cancer DU145 cells. Our data further indicated that ARA 70 will only slightly induce the transcriptional activity of other steroid receptors such as estrogen receptor, glucocorticoid receptor, and progesterone receptor in DU145 cells. Together, these data suggest that AR may need a specific coactivator(s) such as ARA 70 for optimal androgen activity.
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Androgen receptor (AR) is a transcriptional factor that belongs to the member of the steroid receptor superfamily based on its structural similarity (1, 2) . Members of this family are characterized by three major structure regions: a variable amino-terminal domain, a highly conserved cysteine-rich DNA binding domain, and a carboxyl-terminal ligand-binding domain. When bound to androgens and androgen-responsive element, AR can up or down regulate the expression of androgen target genes through a complicated process that may require other adaptors or coactivators (3) .
In addition, a fundamental issue in the steroid hormone regulation is the question of how specific transcription can be achieved in vivo when several receptors, such as AR, glucocorticoid receptor, and progesterone receptor can recognize the same DNA sequence (4, 5) . It has been speculated that some accessory factors may selectively interact with the AR to determine the specificity of AR target gene activation.
To understand further the mechanism of androgen-AR function, we decided to use a yeast two-hybrid system to isolate AR-associated proteins that may contribute the activation of AR. We report here the isolation of the first ligand-dependent AR-associated protein, ARA 70 , which may function as a specific coactivator to enhance the transcriptional activity of AR in prostate DU145 cells.
MATERIALS AND METHODS
Yeast Two-Hybrid Screening. A fusion protein (GAL4AR) containing GAL4 DNA binding domain (GAL4DBD) and carboxyl terminus of AR was used as bait to screen for His synthetase gene (His3) positive clones from 3 ϫ 10 6 transformants of MATCHMAKER human brain library. Mating tests (6) further confirmed that two of the initial 41 potentially positive clones react firmly with AR fusion proteins. ARA 70 was further characterized for androgen effects in the yeast twohybrid system. The transformed yeast Y190 cells were selected
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Ϫ6
M trans-retinoic acid (Fig. 1A, lanes 1-4) or 10
M dihydrotestosterone (DHT) (Fig. 1 A, lanes 7-10) without leucine and tryptophan. GAL4-DBD-TR4 bait was constructed from TR4 orphan receptor without known ligand.
The Far Western Assay. AR-N͞DBD and AR-DBD͞ hormone binding domain (HBD) were expressed, with calculated molecular weight of 66 and 43K, respectively, as polyhistidine fusion protein by inserting the amino-terminal or carboxyl-terminal fragments into the pET 14b (Novagen). Proteins were separated on 10% SDS-polyacrylamide gel. In vitro transcribed͞translated 35 S-labeled ARA 70 was diluted into hybridization buffer, and the filters were hybridized overnight at 4°C in the presence of 1 M DHT. After three washings with hybridization buffer, filters were dried and exposed for autoradiography.
Transient Transfection Assay. The DU145 cells were plated in 60-mm diameter Petri dish at a density of 3.5 ϫ 10 Biochemistry: Yeh and Chang Proc. Natl. Acad. Sci. USA 93 (1996) phosphate method (7) . In each transfection, 3.5 g of reporter mouse mammary tumor virus chloramphenicol acetyltransferase (MMTV-ARE-CAT or MMTV-⌬ARE-CAT) and 1.5 g of pSG5hAR and various amounts of pSG5ARA 70 were cotransfected into the DU145 cells. Relative CAT activity was calculated by the quantification of phosphorimager. The cytomegalovirus-␤-galactosidase construct was used as an internal control, and the relative CAT activity was normalized by the ␤-galactosidase activity.
RESULTS AND DISCUSSION
Identification of the Androgen Receptor-Specific Associated Protein, ARA 70 . To further understand the mechanism of androgen-AR action, we applied a yeast two-hybrid system using the GAL4AR fusion protein as bait to isolate a cDNA encoding ARA 70 , which interacts specifically with AR. In this system, yeast will survive when GAL4AR is co-expressed with ARA 70 in the presence of DHT ( Fig. 1 A and B) . Neither GAL4AR nor ARA 70 was active when ARA 70 was expressed alone or when ARA 70 was co-expressed with GAL4RAR or GAL4TR4 (8) (GAL4 fusion proteins with two other members of the steroid receptor superfamily) (Fig. 1 A) . These data, therefore, clearly suggest that ARA 70 can interact specifically with AR in the yeast cells.
We then tested whether the interaction of ARA 70 with AR in yeast was ligand-dependent. As shown in The RACE-PCR technique (8, 9) was then used to clone the full-length ARA 70 cDNA that encodes a protein of 614 amino acids with a calculated molecular weight of 70 K (Fig. 2) . A search of GenBank indicated that ARA 70 shares 99% homology (three different amino acids in the coding region) with one identified cDNA clone (RET-fused gene, RFG) isolated from human thyroid (10) . Although the biological functions of RFG are mostly unknown, the expression of RFG in thyroid tumor may suggest some potential roles of RFG in thyroid carcinogenesis (10) .
The Tissue Distribution of ARA 70 . Northern blot analysis in mouse indicated that ARA 70 is expressed as an mRNA of ϳ3600 bp in many tissues, including prostate, testis, adrenal gland, and thymus (Fig. 3) . The relative expression of ARA 70 in the following mouse tissues, using adrenal gland as 100%, are: testis, 77%; prostate, 97%; preputial gland, 64%; thymus, 214%; submaxillary gland, 24%; muscle, 41%; heart, 73%; kidney, 37%; lung, 49%; fat pad, 20%; seminal vesicle, spleen, liver, and brain cortex, undetectable. Among the cell lines (LNCaP, MCF-7, Chinese hamster ovary, HeLa, and DU145) we tested, the human prostate cancer cell line, DU145, proved to be the only cell line that did not express ARA 70 (data not shown) and therefore was chosen for further functional studies.
The in Vitro Interaction Between AR and ARA 70 . To further confirm that the interaction that occurred in yeast cells is due to a direct interaction between AR and ARA 70 , we applied an in vitro immunoprecipitation assay with an anti-AR antibody (CW2). We demonstrated that CW2 can co-precipitate the AR and ARA 70 when in vitro transcribed͞translated full-length In vitro transcribed͞translated 35 S-labeled ARA70 was diluted into hybridization buffer, and the filters were hybridized overnight at 4°C in the presence of 1 M DHT. After three washings with hybridization buffer, filters were dried and exposed for autoradiography Biochemistry: Yeh and Chang Proc. Natl. Acad. Sci. USA 93 (1996) human AR and ARA 70 were incubated with it in the lysate mixture (Fig. 4A, lane 7) . This precipitation is specific, as CW2 did not precipitate the ARA 70 in the absence of AR (Fig. 4A , lane 6) and CW2 did not precipitate two other proteins (RXR and TR4 orphan receptors) incubated with AR (Fig. 4A, lanes  8 and 9) . A Far Western assay also demonstrated that ARA 70 can bind to immobilized AR peptide containing DNA binding domain and hormone binding domain (AR-DBD͞HBD), but not the BL21 protein lysate or the AR peptide containing the amino-terminal and DNA binding domain of AR (AR-N͞ DBD) (Fig. 4B) . Together, these data indicate that the association is due to a direct interaction between AR and ARA 70 . Stimulation of the Transcriptional Activity of AR by ARA 70 . DU145 cells were co-transfected with ARA 70 and AR under eukaryotic promoter control. Ligand-free AR has minimal MMTV-ARE CAT reporter activity with or without the presence of ARA 70 (Fig. 5A, lanes 2 and 3) . Addition of DHT results in a 6-fold increase of AR activity (Fig. 5A, lanes 2 versus 4) . Furthermore, this transcriptional activity can be increased to 58 (Ϯ 3.2)-fold (mean Ϯ SEM; n ϭ 4) by the co-transfection of ARA 70 cDNAs in a dose-dependent manner (Fig. 5A, lanes 5-8) . The induced activity reached a plateau at 4.5 g of co-transfected ARA 70 cDNA and the additional ARA 70 beyond 4.5 g (up to 6 g) did not affect the induced activity of AR in DU145 cells. To rule out any indirect effects on the basal activity of the MMTV-ARE-CAT reporter, we removed the ARE DNA fragment from our reporter (MMTV-⌬ARE-CAT). The results showed that ARA 70 induced no activity on this reporter in the presence or in the absence of DHT (Fig. 5A, lanes 9-14) .
We also replaced ARA 70 with another nuclear orphan receptor-associated protein, TR4AP, in the AR:MMTV-ARE CAT reporter assay and found that this protein had no effect in our assay (data not shown). Furthermore, when we replaced DU145 cells with Chinese hamster ovary cells, which express a relative abundance of ARA 70 , we found that although the exogenously transfected ARA 70 did not show a dramatic effect on induction of AR transcriptional activity, the transfection of antisense ARA 70 did partially block the AR transcriptional activity (data not shown). Together, these data strongly suggest that stimulation of AR transcriptional activity by ARA 70 occurs through a specific ligand-bound AR and that the relative amount of AR versus ARA 70 in cells may also play an important role for the activation of AR.
The effect of ARA 70 on transactivation of AR bound to different concentrations of T, DHT, and HF in DU145 cells was also tested. Whereas 10
Ϫ10
M DHT might maximize induced transcriptional activity of AR, T needed a 10-fold higher concentration (10 Ϫ9 M) for maximum activity (Fig. 5B) . HF induced only a few activity at a pharmacological concentration (10 Ϫ6 M). These results are consistent with the data generated from yeast cells (Fig. 1B) and previous reports (12, 13) , which indicated that DHT is a more potent androgen in the prostate. In fact, the greater potency of DHT to modulate the interaction between AR and ARA 70 may actually provide another reason why DHT is a more potent androgen in prostate.
The enhancement of AR transcriptional activity from 6-fold to 58-fold by ARA 70 may expand androgen activity in the (1996) prostate that androgen-AR alone cannot reach. Since we detected ARA 70 in AR-positive LNCaP prostate cancer cells but not in AR-negative DU145 cells, it will be important to determine if the expression of ARA 70 and its ability to interact properly with androgen-AR change during the progression of prostate cancer from an androgen-dependent to an androgenindependent state. ARA 70 Functions As a Specific Activator to Enhance the Transcriptional Activity of AR. We also examined the effect of ARA 70 on the transcriptional activity of several other steroid receptors through their cognate DNA response elements. As shown in Fig. 6 , while ARA 70 can induce the transcriptional activity of AR up to 10-fold, ARA 70 can only slightly enhance (up to 2-fold) the transcription activity of other steroid receptors, such as glucocorticoid receptor (GR), progesterone receptor (PR), and estrogen receptor (ER). These results clearly indicate that ARA 70 is a more specific coactivator for AR.
Several proteins have been demonstrated to interact with other steroid receptors in a ligand-dependent or ligandindependent manner (14-18). However, none of these proteins have been shown to enhance specifically AR-mediated transcriptional activity; therefore, it is likely that ARA 70 has a different mechanism for interacting with AR.
In summary, our data demonstrated that ARA 70 is the first identified ligand-dependent associated protein for AR that may function as a specific coactivator for inducing the transcriptional activity of AR in human prostate cells. Further studying the potential role of ARA 70 may therefore help us to understand better the molecular mechanism of androgen action.
